Abstract:Background Immunoglobulin A nephropathy (IgAN) is an autoimmune disease characterized by the production of galactose‐deficient IgA1 (Gd‐IgA1) and the deposition of immune complexes in the kidney. Exploring the landscape of immune dysregulation in IgAN is valuable for pathogenesis and disease treatment. We conducted Mendelian randomization (MR) to assess the causal correlations between inflammation and IgAN. Methods Based on available genetic datasets, we investigated potential causal links between inflammation and the risk of IgAN using two-sample MR. We used genome-wide association study (GWAS) summary statistics of 5 typical inflammation markers, 41 inflammatory cytokines, and 731 immune cell signatures, accessed from the public GWAS Catalog. The primary method employed for MR analysis was Inverse Variance Weighted (IVW). To confirm consistency across results, four supplementary MR methods were also conducted: MR-Egger, Weighted Median, Weighted Mode, and Simple Mode. To assess pleiotropy, we used the MR-Egger regression intercept test and Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO) test. Cochrane's Q statistic was applied to evaluate heterogeneity. Additionally, the stability of the MR findings was verified through the leave-one-out sensitivity analysis. Results This study revealed that interleukin-7 (IL-7) and stem cell growth factor beta (SCGF-β) were possibly associated with the risk of IgAN according to the IVW approach, with estimated odds ratios (OR) of 1.059 (95 % confidence interval [CI] 1.015 to 1.104, P = 0.008) and 1.043 (95 % CI 1.002 to 1.085, P = 0.037). Five immune traits were identified that might be linked to IgAN risk, each with P -values below 0.01, including natural killer T %T cell (OR = 1.058, 95 % CI: 1.020 to 1.097, P = 0.002), natural killer T %lymphocyte (OR = 1.055, 95 % CI: 1.016 to 1.096, P = 0.006), CD25 ++ CD8 + T cell %T cell (OR = 1.057, 95 % CI: 1.016 to 1.099, P = 0.006), CD3 on effector memory CD4 + T cell (OR = 1.045, 95 % CI: 1.019 to 1.071, P = 0.001), and CD3 on CD28 + CD45RA + CD8 + T cell (OR = 1.042, 95 % CI: 1.016 to 1.068, P = 0.001). CD4 on central memory CD4 + T cell might be a protective factor for IgAN (OR = 0.922, 95 % CI: 0.875 to 0.971, P = 0.002). Moreover, IgAN may be implicated in a high risk of elevated granulocyte colony-stimulating factor (G-CSF) (OR = 1.114, 95 % CI 1.002 to 1.239, P = 0.046). Conclusion Our study revealed exposures among typical inflammation markers, inflammatory cytokines, and immune cell signatures that may potentially linked to IgAN risk by MR analysis. This insight may advance our understanding of the etiology of IgAN and support the development of targeted therapeutic strategies.

Genetically predicted N-Acetyl-L-Alanine mediates the association between CD3 on activated and secreting Tregs and Guillain-Barre syndrome

Lactobacillus Rhamnosus Ameliorates Experimental Autoimmune Neuritis Via Modulation of Gut Microbiota and Metabolites.

Causal relationship between immune cells and Guillain-Barré syndrome: a Mendelian randomization study

Genetic link between celiac disease and autoimmune liver diseases: A two-sample Mendelian randomization study

Causal effects of systemic inflammatory proteins on Guillain-Barre Syndrome: insights from genome-wide Mendelian randomization, single-cell RNA sequencing analysis, and network pharmacology

Genetic association between gut microbiota and the risk of Guillain-Barré syndrome

Peripheral immune markers and amyotrophic lateral sclerosis: a Mendelian randomization study

Low CD3 level is a risk factor for amyotrophic lateral sclerosis: a Mendelian randomization study

Natural killer cells-related immune traits and amyotrophic lateral sclerosis: A Mendelian randomization study

Genetic polymorphisms in Guillain-Barré Syndrome: A field synopsis and systematic meta-analysis

Relationship between Guillain-Barré syndrome and Cardiovascular disease: A bidirectional Mendelian randomization study

Causal role of the pyrimidine deoxyribonucleoside degradation superpathway mediation in Guillain-Barré Syndrome via the HVEM on CD4 + and CD8 + T cells

Exploring the causal role of gut microbiota in giant cell arteritis: a Mendelian randomization analysis with mediator insights

Genetic determinants of cerebrospinal fluid metabolites and risk of Guillain-Barré syndrome: A bidirectional two-sample Mendelian randomization study

The Causal Role of Circulating Amino Acids on Neurodegenerative Disorders: A Two‐sample Mendelian Randomization Study

Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID‐19–associated Guillain‐Barré syndrome

Herpesvirus entry mediator on T cells as a protective factor for myasthenia gravis: A Mendelian randomization study

A Mendelian randomization study investigating the causal relationships between inflammation and immunoglobulin A nephropathy

The potential protective role of peripheral immunophenotypes in Alzheimer's disease: a Mendelian randomization study

Gut microbiota and autoimmune neurologic disorders: a two-sample bidirectional Mendelian randomization study

Causal role of immune cells in generalized anxiety disorder: Mendelian randomization study